{"created":"2023-05-15T11:23:38.188499+00:00","id":3378,"links":{},"metadata":{"_buckets":{"deposit":"f13ee284-71b1-48f5-8ab1-da046edda236"},"_deposit":{"created_by":1,"id":"3378","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"3378"},"status":"published"},"_oai":{"id":"oai:showa.repo.nii.ac.jp:00003378","sets":["1:51:271:272"]},"author_link":["11409","11413","11410","11414","11415","11416","11417","11412","11418","11411","11408","11407","11406"],"item_10002_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2020-04"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"55","bibliographicPageStart":"43","bibliographicVolumeNumber":"32","bibliographic_titles":[{"bibliographic_title":"The Showa University journal of medical sciences"}]}]},"item_10002_description_6":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Survivors of ventricular fibrillation out-of-hospital cardiac arrest（VF-OHCA）due to potentially reversible causes such as acute coronary syndrome（ACS）, vasospastic angina and electrolyte abnormalities are considered low risk for recurrent arrhythmia. Accordingly, implantable cardioverter-defibrillator therapy is not routinely recommended in such patients. We investigated the risk of mortality and the value of ICD therapy for VF-OHCA. Among 2,248 cardiopulmonary arrest patients presenting at our hospital, we retrospectively investigated 110 patients with VF-OHCA who were admitted for treatment. We divided the patients based on ICD（n＝71） or No-ICD status（n＝39）, and on reversible cause（n＝70） or irreversible cause（n＝40）. The groups were compared for baseline characteristics, mortality and ICD therapies. Patients with a reversible cause had a significantly lower rate of ICD implantation than those with an irreversible cause（P＝0.03）. Males in the ICD group presented more frequently than those in the No-ICD group, and cardiac mortality in patients with acute coronary syndrome was significantly lower with ICD therapy than without ICD（P＝0.04）. The rate of appropriate ICD therapies with a reversible cause was 28％, and the first ICD therapy was highest within 1 year post-implantation. Patients with VF-OHCA due to a reversible cause remain at high risk of recurrent ventricular arrhythmias, suggesting that ICD implantation is a reasonable approach in such cases.","subitem_description_type":"Abstract"}]},"item_10002_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Showa University Society"}]},"item_10002_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.15369/sujms.32.43"}}]},"item_10002_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"2185-0968"}]},"item_10002_version_type_20":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"GOKAN, Toshihiko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"KAWAMURA, Mitsuharu"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"ARAI, Shuhei"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"YOSHIKAWA, Kosuke"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"TANISAWA, Hiroki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"OGAWA, Ko"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"OCHI, Akinori"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"ONISHI, Yoshimi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"MUNETSUGU, Yumi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"ITO, Hiroyuki"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"ONUKI, Tatsuya"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"KOBAYASHI, Youichi"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"SHINKE, Toshiro"}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2020-06-02"}],"displaytype":"detail","filename":"S32_43.pdf","filesize":[{"value":"238.7 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"S32_43.pdf","url":"https://showa.repo.nii.ac.jp/record/3378/files/S32_43.pdf"},"version_id":"687444f2-55a2-4582-9fb9-9c5851659e22"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper"}]},"item_title":"Effect of Implantable Cardioverter-defibrillator Therapy for Ventricular Fibrillation Patients with Out-of-hospital Cardiac Arrest","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Effect of Implantable Cardioverter-defibrillator Therapy for Ventricular Fibrillation Patients with Out-of-hospital Cardiac Arrest"}]},"item_type_id":"10002","owner":"1","path":["272"],"pubdate":{"attribute_name":"公開日","attribute_value":"2020-06-01"},"publish_date":"2020-06-01","publish_status":"0","recid":"3378","relation_version_is_last":true,"title":["Effect of Implantable Cardioverter-defibrillator Therapy for Ventricular Fibrillation Patients with Out-of-hospital Cardiac Arrest"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-15T12:32:08.028811+00:00"}